MAPT and Alzheimer disease: An increased concentration of YKL-40 was also associated with classical AD biomarkers: Aβ42/40 ratio (r = −0.24; p = 0.030), tau (r = 0.45; p < 0.001), and ptau181 (r = 0.58; p < 0.001).